EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Mechanisms of Genistein in Breast Cancer: From Oxidative Stress to Oncogenic Pathway Inhibition

Md. Sakib Al Hasan, Md Imran Hossain, Rakib Hossan, Hasna Banu, Khadija Akter, Md Showkoth Akbor, Proma Mandal, Md. Mizan, Asmaul Husna Bristy, Umme Habiba Sumaya

Journal of Chemistry Insights and Discoveries · 2025

DOI: 10.71193/jcid.20250006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chemistry Insights and Discoveries, 2025. Verfasst von Md. Sakib Al Hasan und 9 weiteren Autor:innen. Die Arbeit nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genistein (GT), a soy-derived isoflavone, have received attention due to their possible anticancer effects. The present research is designed to explore the anticancer potential of GT in the therapeutic management of breast cancer (BC) with molecular mechanisms. For this, data have been collected from plausible different online databases, including PubMed, Web of Science, Google Scholar, PubChem, ScienceDirect, Scopus, Springer Link, and Wiley Online. The findings highlight GT’s potential to reduce oxidative damage, induce apoptosis, and modulate the cell lifecycle in BC cells. It inhibits cancer cell proliferation by affecting the human epidermal growth factor receptor 2 (HER2), phosphoinositide 3-kinase/ protein kinase B (PI3K/AKT), and hedgehog regulatory pathways. Moreover, GT exhibits promising pharmacokinetic properties, including high intestinal absorption (95.5%) and strong Caco-2 permeability, with metabolism primarily via CYP1A2 and CYP2C19. However, its poor blood-brain barrier (BBB) permeability and low water solubility present difficulties to the systemic bioavailability. Toxicological investigations demonstrate a dose-dependent effect of GT, with large dosages causing toxicity and low concentrations showing therapeutic potential. Clinical studies emphasize its complex involvement in BC, with differing findings on benefits and risks, indicating the need for additional safety and efficacy study.

Zitieren

APA

Hasan, M. S. A., Hossain, M. I., Hossan, R., Banu, H., Akter, K., Akbor, M. S., Mandal, P., Mizan, M., Bristy, A. H., & Sumaya, U. H. (2025). Molecular Mechanisms of Genistein in Breast Cancer: From Oxidative Stress to Oncogenic Pathway Inhibition. Journal of Chemistry Insights and Discoveries. https://doi.org/10.71193/jcid.20250006

Vancouver

Hasan MSA, Hossain MI, Hossan R, Banu H, Akter K, Akbor MS, et al. Molecular Mechanisms of Genistein in Breast Cancer: From Oxidative Stress to Oncogenic Pathway Inhibition. Journal of Chemistry Insights and Discoveries. 2025. doi:10.71193/jcid.20250006

BibTeX
@article{Hasan2025,
  author = {Hasan, Md. Sakib Al and Hossain, Md Imran and Hossan, Rakib and Banu, Hasna and Akter, Khadija and Akbor, Md Showkoth and Mandal, Proma and Mizan, Md. and Bristy, Asmaul Husna and Sumaya, Umme Habiba},
  title = {Molecular Mechanisms of Genistein in Breast Cancer: From Oxidative Stress to Oncogenic Pathway Inhibition},
  journal = {Journal of Chemistry Insights and Discoveries},
  year = {2025},
  doi = {10.71193/jcid.20250006}
}
Kostenlos starten →